Creatinine on study day 3 , a secondary outcome , was significantly lower in the acetaminophen group ( 1.0 mg/dL ; interquartile range , 0.6-1 .4 ) when compared with that in the placebo ( 1.3 mg/dL ; interquartile range , 0.83-2 .0 ; p = 0.039 ) .